Sourcing Guide

Buy Kisspeptin

Research-grade Kisspeptin-10 with purity documentation for GnRH axis and reproductive endocrinology research

>=98% purity by HPLCLyophilized powderUSA Domestic

Research Context

Kisspeptin is the master upstream regulator of the GnRH pulse generator, discovered as a reproductive regulator following the 2003 Seminara et al. NEJM paper. Human clinical trials from Dhillo and Jayasena at Imperial College London have characterized its role in hypothalamic amenorrhea and hypogonadism.

Full Kisspeptin Research Reference →

Kisspeptin Research Supply

>=98% purity by HPLC with batch-specific CoA. Lyophilized powder.

View Product PageRead Research Reference

Sourcing Guide

What Researchers Look For

Kisspeptin exists in multiple isoforms (Kisspeptin-54, -13, -14, -10), and researchers should specify the isoform appropriate for their research design. Kisspeptin-10 is the most commonly used research isoform due to its manageable size (10 amino acids, approximately 1302 Da) and retained full GPR54 agonist activity. Researchers should verify both HPLC purity and mass spectrometry molecular weight for the specific isoform being used, as isoform identity is critical for replicating published protocols.

Why Spartan Peptides

Spartan Peptides supplies Kisspeptin for research with a minimum 98% HPLC purity and batch-specific certificate of analysis documentation. The lyophilized format maintains research-grade stability for GPR54 assay and in vivo reproductive endocrinology study applications.

Specifications

Purity Standard>=98% purity by HPLC
FormatLyophilized powder
StorageStore lyophilized at -20 degrees C. Reconstituted, stable 30 days at 4 degrees C.
OriginUSA domestic supply
DocumentationBatch-specific certificate of analysis

Sourcing FAQ

Order Research-Grade Kisspeptin

>=98% purity by HPLC. Lyophilized powder. Batch-specific CoA. Domestic US supply with same-day dispatch before 2 PM EST.

All compounds are strictly for in-vitro research use only and not intended for human consumption.